MediciNova
Price & Volume
Stats
See more52W Range | $1.13-$2.55 |
Market Cap | $61.3M |
Shares Short | 127,510 |
Financials
See moreRevenue (12 Mos) | $134,599 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $18,250 |
Diluted EPS | -$0.25 |
News
See moreYahoo Finance • 9 days ago
MediciNova Announces Completion of Patient Enrollment in COMBAT-ALS Phase 2b/3 Clinical Trial of MN-166 (ibudilast)
Yahoo Finance • 23 days ago
MediciNova Provides Shareholder Update on Key Developments
Yahoo Finance • 28 days ago
MediciNova to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Yahoo Finance • last month
MediciNova Achieves Enrollment in COMBAT-ALS Clinical Trial
About
CEO | Dr. Yuichi Iwaki M.D., Ph.D. |
CFO | Mr. Jason J. Kruger CPA |
Address | 4275 Executive Square, La Jolla, CA, United States, 92037 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 13 |
